Sanofi-Aventis (Thailand) Ltd.

Categories

Pharmaceutical

About Us

Sanofi-aventis Thailand is part of Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi has its roots registered as Hoechst in Thailand since 1959. The company today has grown organically as well as through various mergers and acquisitions; at present there are almost 450 employees.

Sanofi group in Thailand is composed of two companies:
- Sanofi-aventis (Thailand) Ltd. which addresses the pharmaceutical and consumer healthcare markets whereby the company also has its footprint in rare disease market;
- Sanofi Pasteur Ltd. which focuses on the human vaccine market. The company has established, in 1997, a joint venture company with the Government Pharmaceutical Organization (GPO) and the CPB Equity Co., Ltd., called the GPO-MBP Ltd. manufacturing vaccines for local public needs as well as for export.

Rep/Contact Info

Philippe Leroy
Head of Established Product Business Unit, Thailand, Malaysia, Singapore
Card image cap
Mrs. Sommawan Lowhaphandu
Public Affairs Manager
Card image cap
Chamaiporn Noonbhakdi
Head of Public Affairs, Thailand
Siripong (James) Soysopee
Public Affairs
Card image cap
Marine Queniart Stojanovic
General Manager, General Medicines, TMS MCO ( Thailand, Malaysia, Singapore) & Country Lead Thailand and Malaysia
Mantana Tanprasert
General Manager